Four key decisions await Trump: reinstating the Mexico City Policy; withdrawing from WHO, abandoning the Pandemic Prevention Treaty and de-authorizing PEPFAR, the HIV prevention program.
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.